Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 476
Immune Disorders Drugs 202
Drug Discovery 170
Cardiovascular Drugs 157
Infectious Diseases Drugs 135
Biopharmaceuticals 130
Clinical Trials 125
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 85
Hematological Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 62
Diabetes Drugs 55
Dermatological Drugs 55
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 42
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Drug Delivery 37
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 32
Infusions and Injectables 30
Liver Cancer Drugs 28
Analgesics 25
Drugs by Therapeutic Area 24
Bladder Cancer Drugs 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Schizophrenia Drugs 19
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Breast Cancer Drugs 14
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Alzheimer's Disease Drugs 8
Optical Disorders Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

2,452 Results (Page 13 of 123)
- Relevance
  Sort by

Adult Malignant Glioma Therapeutics Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4110EUR$4,490USD£3,493GBP

Pediatric Neuroblastoma Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4110EUR$4,490USD£3,493GBP

Glioma Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4110EUR$4,490USD£3,493GBP

Alzheimer's Disease Market (2nd edition) by Type of Treatment (Symptomatic and Disease Modifying), Symptomatic Indications (Dementia, Insomnia and Other Psychological Symptoms) and Geography (North America, Europe and Asia-Pacific), 2021-2030

 Report
September 2021
150 Pages
Global

From

€4393EUR$4,799USD£3,734GBP

Non-Alcoholic Steatohepatitis (NASH) (Gastrointestinal) - Drugs in Development, 2021

 Drug Pipelines
March 2021
Global

From

€2289EUR$2,500USD£1,945GBP

NEED HELP FINDING THE RIGHT PRODUCT? Farid will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Non-Small Cell Lung Cancer (NSCLC) Market Report 2025

 Report
March 2025
200 Pages
Global

From

€4110EUR$4,490USD£3,493GBP

Progressive Multifocal Leukoencephalopathy Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
January 2024
208 Pages
Global

€4572EUR$4,995USD£3,886GBP

Antibacterial Drugs Market by Drug Class (Aminoglycosides, Beta-Lactams, Glycopeptide), Route of Administration (Inhalation, Intramuscular, Intravenous), Spectrum of Activity, Mechanism of Action, Indication, Point of Sale, Distribution Channel - Global Forecast 2025-2030

 Report
March 2025
187 Pages
Global

From

€3245EUR$3,545USD£2,758GBP

€3606EUR$3,939USD£3,064GBP

Non-Small Cell Lung Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
February 2025
183 Pages
Global

From

€4119EUR$4,500USD£3,501GBP

Chronic Lymphocytic Leukemia (CLL) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032

 Report
September 2023
65 Pages
Global

From

€9149EUR$9,995USD£7,776GBP

Acute Myeloid Leukemia (AML) Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032

 Report
September 2023
79 Pages
Global

From

€9149EUR$9,995USD£7,776GBP

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025

 Report
April 2025
750 Pages
Global

From

€3657EUR$3,995USD£3,108GBP

Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2025

 Report
April 2025
250 Days
Global

From

€3657EUR$3,995USD£3,108GBP

Brain Tumor Drugs Market Forecasts from 2023 to 2028

 Report
November 2023
140 Pages
Global

From

€4074EUR$4,450USD£3,462GBP

Lipid Nanoparticles in Drug Delivery: Intellectual Property Landscape

 Report
March 2023
182 Pages
Global

From

€1738EUR$1,899USD£1,477GBP

Antibiotics Market by Action Mechanism, Drug Class, Spectrum, Category, Application, Route of Administration, Distribution Channel - Global Forecast 2025-2030

 Report
October 2024
182 Pages
Global

From

€3245EUR$3,545USD£2,758GBP

€3606EUR$3,939USD£3,064GBP

Beta Lactam & Beta Lactamase Inhibitors Market by Drug Class, Disease, Route of Administration, Distribution Channels, End User, Drug Type - Global Forecast 2025-2030

 Report
October 2024
185 Pages
Global

From

€3245EUR$3,545USD£2,758GBP

€3606EUR$3,939USD£3,064GBP

Lung Cancer Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
110 Pages
Global

From

€4348EUR$4,750USD£3,695GBP

Non-Small Cell Lung Cancer (NSCLC) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
110 Pages
Global

From

€4348EUR$4,750USD£3,695GBP

Ovarian Cancer Diagnostics And Therapeutics Market Report and Forecast 2024-2032

 Report
December 2023
195 Pages
Global

From

€4530EUR$4,949USD£3,850GBP

2,452 Results (Page 13 of 123)
- 1
- 11
- 12
- 13
- 14
- 15

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.